Institutional investors purchased a net $668.5 thousand shares of ZIOP during the quarter ended September 2017 and now own 33.77% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.4 Million shares of ZIOPHARM Oncology Inc
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 468.3 Thousand shares of ZIOPHARM Oncology Inc
THE VANGUARD GROUP, INC. Bought 302.6 Thousand shares of ZIOPHARM Oncology Inc